Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03603600 · ClinicalTrials.gov registry record · NA
Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 501
- Enrollment target
NCT03603600 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 501 participants.
The verdict
NCT03603600, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 501 participants
- Enrollment target
Study Summary
The objective of the study is to evaluate the safety and effectiveness of the enVista trifocal intraocular lens when implanted in the capsular bag.
Interventions
- DEVICE enVista MX60E
- DEVICE enVista MX60EF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 501 participants |
| Start Date | 2018-05-31 |
| Est. Completion | 2023-05-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03603600
The ClinicalTrials.gov registry entry for NCT03603600 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 501 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which enVista MX60E is the first listed.
NCT03603600 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03603600 about?
NCT03603600 is a clinical study titled "Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens". The objective of the study is to evaluate the safety and effectiveness of the enVista trifocal intraocular lens when implanted in the capsular bag.
What is the current status of trial NCT03603600?
This trial is currently completed. It is a NA study. The enrollment target is 501 participants. The study started on 2018-05-31. Estimated completion is 2023-05-04.
What interventions are being tested in trial NCT03603600?
The interventions under investigation include: enVista MX60E (DEVICE), enVista MX60EF (DEVICE).
Who is sponsoring clinical trial NCT03603600?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.